Cephalexin
Rank #409 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$21.4M
Total Cost
2,407,718
Total Claims
$21.4M
Total Cost
80,257
Prescribers
$9
Cost per Claim
1,885,174
Beneficiaries
2,550,769
30-Day Fills
$267
Avg Cost/Provider
30
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$21.4M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $21.4M total
🔎 Data Overview
At $9.00 per prescription, this is an affordable generic medication. Wider use of affordable generics like this could save Medicare billions annually.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Cephalexin
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Michele Weiberg | Infectious Disease | Kokomo, IN | 33 | $14K |
| 2 | Ross Campbell | Dermatology | Watkinsville, GA | 2,246 | $11K |
| 3 | Scott Warren | Dermatology | Jacksonville, FL | 1,694 | $10K |
| 4 | Kristin Constance | Infectious Disease | Hutchinson, KS | 182 | $8,698 |
| 5 | Monika Srivastava | Dermatology | Vero Beach, FL | 1,077 | $8,503 |
| 6 | Glenn Kershen | Urology | Saginaw, MI | 683 | $8,187 |
| 7 | Scott Macdiarmid | Urology | Greensboro, NC | 484 | $7,814 |
| 8 | Lonnie Klein | Urology | Safety Harbor, FL | 522 | $7,746 |
| 9 | Sun Kim | Urology | San Bernardino, CA | 288 | $7,689 |
| 10 | Melody Denson | Urology | Austin, TX | 437 | $7,594 |
| 11 | Helen Jahna | Nurse Practitioner | Rochester, NY | 159 | $7,532 |
| 12 | Phillip Hall | Micrographic Dermatologic Surgery | Dayton, OH | 976 | $7,126 |
| 13 | James Eaton | Urology | Stockbridge, GA | 888 | $7,107 |
| 14 | Margaret Wolf | Urology | Clinton, IA | 687 | $6,899 |
| 15 | Vijay Goli | Urology | Las Vegas, NV | 177 | $6,868 |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 406 | Chlorthalidone (Chlorthalidone) | $21.8M | 966,780 |
| 407 | Ondansetron (Ondansetron Odt) | $21.5M | 1,261,950 |
| 408 | Asciminib Hydrochloride (Scemblix) | $21.4M | 830 |
| 409 | Cephalexin (Cephalexin) | $21.4M | 2,407,718 |
| 410 | Teprotumumab-Trbw (Tepezza) | $21.4M | 389 |
| 411 | Nystatin (Nystatin) | $21.4M | 908,177 |
| 412 | Desvenlafaxine Succinate (Desvenlafaxine Succinate Er) | $21.3M | 257,580 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology